3-179242978-CT-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_171830.2(KCNMB3):c.753delA(p.Val252fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0659 in 1,607,104 control chromosomes in the GnomAD database, including 4,862 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.10 ( 1183 hom., cov: 28)
Exomes 𝑓: 0.062 ( 3679 hom. )
Consequence
KCNMB3
NM_171830.2 frameshift
NM_171830.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.485
Genes affected
KCNMB3 (HGNC:6287): (potassium calcium-activated channel subfamily M regulatory beta subunit 3) MaxiK channels are large conductance, voltage and calcium-sensitive potassium channels which are fundamental to the control of smooth muscle tone and neuronal excitability. MaxiK channels can be formed by 2 subunits: the pore-forming alpha subunit and the modulatory beta subunit. The protein encoded by this gene is an auxiliary beta subunit which may partially inactivate or slightly decrease the activation time of MaxiK alpha subunit currents. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 22. [provided by RefSeq, Jul 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 3-179242978-CT-C is Benign according to our data. Variant chr3-179242978-CT-C is described in ClinVar as [Benign]. Clinvar id is 403000.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.207 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNMB3 | NM_171830.2 | c.753delA | p.Val252fs | frameshift_variant | 3/3 | ENST00000392685.7 | NP_741981.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNMB3 | ENST00000392685.7 | c.753delA | p.Val252fs | frameshift_variant | 3/3 | 1 | NM_171830.2 | ENSP00000376451.2 |
Frequencies
GnomAD3 genomes AF: 0.100 AC: 15213AN: 151834Hom.: 1179 Cov.: 28
GnomAD3 genomes
AF:
AC:
15213
AN:
151834
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0624 AC: 15188AN: 243254Hom.: 780 AF XY: 0.0595 AC XY: 7810AN XY: 131338
GnomAD3 exomes
AF:
AC:
15188
AN:
243254
Hom.:
AF XY:
AC XY:
7810
AN XY:
131338
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0623 AC: 90713AN: 1455152Hom.: 3679 Cov.: 31 AF XY: 0.0610 AC XY: 44119AN XY: 723592
GnomAD4 exome
AF:
AC:
90713
AN:
1455152
Hom.:
Cov.:
31
AF XY:
AC XY:
44119
AN XY:
723592
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.100 AC: 15222AN: 151952Hom.: 1183 Cov.: 28 AF XY: 0.0954 AC XY: 7088AN XY: 74276
GnomAD4 genome
AF:
AC:
15222
AN:
151952
Hom.:
Cov.:
28
AF XY:
AC XY:
7088
AN XY:
74276
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
86
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 1450/12518=11.5% - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at